Clinical trial
Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
NCT00460031 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00460031 |
|---|---|
| Title | Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy |
| Official title | Phase II Trial to Assess the Activity of Ketoconazole Plus Lenalidomide in Patients With Prostate Cancer Progressive After Androgen Deprivation |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | ketoconazole, lenalidomide, therapeutic hydrocortisone |
| Enrollment | 34 |
| Start date | Sep 1, 2006 |
| Primary completion | Aug 31, 2010 |
| Completion | Aug 31, 2010 |
| First posted | Apr 13, 2007 |
| Last update posted | Jul 24, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: